This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.29 Firm Fixed Price delivery order contract is for the supply of 4,566,659,449 units of the ROTATEQ vaccine, a critical pharmaceutical product used for disease prevention. The contract has an ultimate completion date of December 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's extensive capabilities in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other critical supplies, to federal agencies and military healthcare systems.
Generated 3/10/25, 9:50 AM